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Integrin-mediated traction force enhances 
paxillin molecular associations and adhesion 
dynamics that increase the invasiveness of tumor 
cells into a three-dimensional extracellular matrix
ABSTRACT Metastasis requires tumor cells to navigate through a stiff stroma and squeeze 
through confined microenvironments. Whether tumors exploit unique biophysical properties 
to metastasize remains unclear. Data show that invading mammary tumor cells, when cul-
tured in a stiffened three-dimensional extracellular matrix that recapitulates the primary tu-
mor stroma, adopt a basal-like phenotype. Metastatic tumor cells and basal-like tumor cells 
exert higher integrin-mediated traction forces at the bulk and molecular levels, consistent 
with a motor-clutch model in which motors and clutches are both increased. Basal-like non-
malignant mammary epithelial cells also display an altered integrin adhesion molecular orga-
nization at the nanoscale and recruit a suite of paxillin-associated proteins implicated in inva-
sion and metastasis. Phosphorylation of paxillin by Src family kinases, which regulates 
adhesion turnover, is similarly enhanced in the metastatic and basal-like tumor cells, fostered 
by a stiff matrix, and critical for tumor cell invasion in our assays. Bioinformatics reveals an 
unappreciated relationship between Src kinases, paxillin, and survival of breast cancer pa-
tients. Thus adoption of the basal-like adhesion phenotype may favor the recruitment of 
molecules that facilitate tumor metastasis to integrin-based adhesions. Analysis of the physi-
cal properties of tumor cells and integrin adhesion composition in biopsies may be predictive 
of patient outcome.
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and metastasis. However, the colonization of distant metastasis sites 
requires passage through a series of narrow constrictions. This 
would seem to pose a contradiction because a stiffened tumor cell 
should have a distinct disadvantage when attempting to navigate 
confined microenvironments during the process of metastasis.
One plausible explanation that could link matrix mechanics, ad-
hesion dynamics, and metastatic potential may reside in the obser-
vation that metastatic tumor cells often exhibit traits consistent with 
an epithelial-to-mesenchymal transition (EMT)—a developmental 
process that is often hijacked by cancer cells (Egeblad et al., 2010; 
Taube et al., 2010; Craene and Berx, 2013; Jung et al., 2015). An 
EMT allows formerly epithelial cells to access a mesenchymal form 
of cell migration that conceivably facilitates cancer cell invasion 
within dense ECMs, permitting their efficient dissemination to form 
distant metastatic colonies (Chaffer and Weinberg, 2011; Craene 
and Berx, 2013; Lamouille et al., 2014). Canonical EMT is character-
ized by expression of key transcriptional regulators, including Twist, 
Snail, and Slug, leading to a loss in cadherin-dependent cell–cell 
adhesion and apical-basal polarity and increased cell–ECM adhe-
sion and matrix metalloproteinase (MMP) expression (Yilmaz and 
Christofori, 2009; Przybyla et al., 2016). Moreover, whereas an EMT-
like transition can be triggered by exposure to chemokines such as 
transforming growth factor β (TGFβ), it is also promoted by a stiff 
ECM that is located at the invasive front of tumors (Acerbi et al., 
2015; Wei et al., 2015; Przybyla et al., 2016).
Of importance, the idea that tumor cells require an EMT to metas-
tasize and that this transformation is associated with reduced cortical 
tension has been questioned (Thoelking et al., 2010; Buckley et al., 
2012; Schneider et al., 2013; Fischer et al., 2015; Zheng et al., 2015). 
In some circumstances, metastasis is favored by tumor aggregates 
(Friedl et al., 2012; Nguyen-Ngoc et al., 2012; Cheung et al., 2016). 
Furthermore, intravital imaging clearly illustrates that tumor cells can 
invade as cellular collectives (Gaggioli et al., 2007; Hidalgo-Carcedo 
et al., 2010; Manning et al., 2015), a finding that accords well with the 
observation that metastatic cells often retain E-cadherin expression 
(Cheung et al., 2013; Aceto et al., 2014). A plausible alternative ex-
planation for the apparently disparate theories that argue for either 
single EMT or collective tumor metastasis is that tumor cells may 
engage in a “partial” or “transient” EMT to disseminate (Chaffer and 
Weinberg, 2011; Jolly et al., 2015, 2016). Consistent with this propo-
sition, live-cell imaging of tumor aggregates with a high propensity 
to metastasize revealed that the leader “invading” cells exhibited a 
basal-epithelial phenotype (for convenience, “basal-like”), with fea-
tures reminiscent of a partial EMT (Cheung et al., 2013).
In summary, although evidence indicates that matrix mechanical 
properties can exert strong effects on cancer metastasis, the mole-
cular mechanisms are poorly understood. In particular, whether a 
stiff ECM could foster tumor metastasis by inducing a “basal-like” or 
pseudo-EMT phenotype via mechanical, integrin-mediated signal-
ing has yet to be determined. Moreover, whether this “basal-like 
switch” endows tumor cells with biophysical properties that potenti-
ate the metastasis of the EMT-like cells and, if so, how, are not 
known. To investigate these possibilities, we interrogated the rela-
tionship between integrin adhesion dynamics, composition, and 
forces and the cellular biophysical properties that favor tumor cell 
invasion within a confined, stiffened three-dimensional (3D) ECM.
RESULTS
ECM stiffness stimulates tumor cell invasion and induces a 
basal-like phenotype
We first asked whether a stiffened tumor ECM could promote the 
metastatic behavior of mammary tumors by inducing a basal-like, 
INTRODUCTION
Metastasis is the main cause of death in patients with malignant tu-
mors (Weigelt et al., 2005; Johnson et al., 2013; Lobbezoo et al., 
2015). Tumor metastasis proceeds through a series of critical steps 
that include invasion of malignant cells across the basement mem-
brane and their directed migration into the parenchyma, where they 
form invasive carcinomas (Rowe and Weiss, 2008; Egeblad et al., 
2010). Thereafter, to metastasize, the malignant cells must migrate 
through the interstitial extracellular matrix (ECM) toward blood ves-
sels and intravasate into the vasculature, where they can circulate as 
single cells, as cellular aggregates, or within fibrin-rich emboli (Mas-
sagué and Obenauf, 2016). Eventually, the disseminated “circulat-
ing” tumor cells either die or adhere to the capillaries of distal tis-
sues, where they can extravasate. Once at the secondary site, the 
tumor cells must proliferate and recruit a new vasculature to form 
metastases (Nguyen et al., 2009; Telerman and Amson, 2009; Chaf-
fer and Weinberg, 2011). Each of these steps favors tumor cells that 
migrate efficiently through a dense, collagen- and fibronectin-rich 
ECM, as well as cells that are able to retain their viability during in-
travasation and extravasation—processes that demand consider-
able cellular and nuclear squeezing and distortion (Friedl and Wolf, 
2003; Egeblad et al., 2010; Roussos et al., 2011; Bravo-Cordero 
et al., 2012; Nguyen-Ngoc et al., 2012; Denais et al., 2016). Despite 
the clinical importance of metastasis and an appreciation of the 
physical hurdles that a tumor cell must overcome in order to dis-
seminate, it remains unclear whether tumor cells exploit specific 
biophysical states or acquire unique mechanical properties to par-
ticipate in the metastatic journey.
Cancer cell invasion and metastasis are influenced by the me-
chanical properties of the primary tumor and in particular the stiff-
ness of the stromal ECM (Paszek et al., 2005; Levental et al., 2009; 
Pickup et al., 2013; Bae et al., 2014; Mouw et al., 2014; Rubashkin 
et al., 2014a; Acerbi et al., 2015; Kai et al., 2016). A stiffened ECM 
fosters malignant transformation and metastasis of mammary tissue 
in vivo and stimulates the invasion of human and murine mammary 
epithelial cells (MECs) in vitro (Paszek et al., 2005; Levental et al., 
2009; Schedin and Keely, 2011; Pickup et al., 2013; Rubashkin et al., 
2014a). The invasive front of human breast tumors is also stiffer, and 
the level of stiffness correlates with human breast tumor aggression 
(Acerbi et al., 2015). These findings are consistent with the general 
observation that cells tune their cytoskeletal tension to the stiffness 
of their underlying ECM (Engler et al., 2004; Discher et al., 2005; 
Paszek et al., 2005; Yeung et al., 2005; Saha et al., 2008; Butcher 
et al., 2009; Allen et al., 2012; Cosgrove et al., 2014; Chaudhuri 
et al., 2015). Invading tumor cells engage the ECM through integ-
rins, a class of heterodimeric, transmembrane proteins that link the 
cytoskeleton to the surrounding ECM. In response to a stiff ECM, 
integrin receptors assemble into focal adhesions (FAs), micrometer-
sized assemblies consisting of hundreds of proteins that, in addition 
to their mechanical roles, mediate signaling through multiple path-
ways (Hoffman et al., 2011). Mechanically activated signaling via in-
tegrin-based adhesions not only enhances tumor cell growth and 
survival, but it also drives tumor cell invasion and migration (Jaalouk 
and Lammerding, 2009; DuFort et al., 2011; Batra et al., 2012; 
Carisey et al., 2013; Ross et al., 2013; Yao et al., 2014; Rubashkin 
et al., 2014b; Paluch et al., 2015). Consistently, treatments that in-
hibit FA formation or that ablate FA signaling reduce cancer pro-
gression and metastasis (White et al., 2004; Huveneers et al., 2007; 
Provenzano et al., 2008; Sulzmaier et al., 2014; Winograd-Katz 
et al., 2014). These observations support a picture in which a stiff-
ened stroma, contractile cancer cell cytoskeleton, and integrin-de-
pendent intracellular signaling combine to support cancer growth 
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This basal-like phenotype included loss of junctional β-catenin, reor-
ganization of actin into linearized bundles parallel to the axis of inva-
sion, and acquisition of cytokeratin K14 in the leader cells, reminis-
cent of, but not identical to, the PyMT MECs that had undergone an 
EMT in response to TGFβ (Figure 1, e and f, and Supplemental 
Figure S1). Furthermore, expression of a knock-in IRES (internal ribo-
somal entry site) yellow fluorescent protein (YFP) Snail reporter (Ye 
et al., 2015) indicated that only the invading PyMT leader cells 
within the stiff gels had abundant Snail transcripts that approxi-
mated the level uniformly expressed by all cells in PyMT colonies 
that had undergone a complete EMT (Figure 1g). These findings are 
consistent with the idea that a stiffened ECM could promote tumor 
metastasis by inducing a basal-like or partial EMT phenotype.
Metastatic tumor cells and tumor cells with a basal-like 
phenotype exhibit enhanced invasion within confined 
spaces
A prerequisite for tumor metastasis is the efficient migration of tu-
mor cells through a dense and stiffened ECM, followed by their in-
travasation into the vasculature and extravasation into the meta-
static site. These behaviors would plausibly be favored by 
more-compliant cells, as predicted to be exhibited by cells with ei-
ther a basal or a mesenchymal phenotype after EMT (Sahai, 2007; 
invasive phenotype (Pickup et al., 2013). We examined the behavior 
of mouse tumor colonies (Borowsky et al., 2005) generated by grow-
ing mammary epithelial cell (MEC) PyMT tumor cells within a recon-
stituted basement membrane (rBM; 3–5 d) to form colonies, fol-
lowed by their embedment within a 3D collagen/fibronectin 
bioreactor (72 h), where they were either maintained without modi-
fication or subjected to uniaxial stretch (10%; 72 h). The uniaxial 
stretch induces local strain stiffening of the collagen gel, increasing 
its stiffness fivefold (from ∼0.5 to ∼2.5 kPa) without altering bulk 
ECM concentration or pore size (Cassereau et al., 2015; Figure 1, a 
and b). Phase contrast images of colonies 72 h after their embed-
ment and manipulation showed that the PyMT tumor colonies within 
the soft collagen/fibronectin gels exhibited little to no invasion. 
However, PyMT tumor colonies subjected to a stiffened ECM in-
vaded significantly, although not to the same extent as those treated 
with TGFβ to induce an EMT (Figure 1, c, and quantified in d). On 
further investigation, confocal images revealed that the PyMT colo-
nies within the soft (∼0.5 kPa) collagen/fibronectin hydrogels re-
tained their epithelial phenotype, as indicated by β-catenin localiza-
tion to cell–cell junctions, maintenance of cortical actin organization, 
and intense cytokeratin K8/18 expression (Figure 1, e and f, and 
Supplemental Figure S1). In contrast, the PyMT MECs invading into 
the stiffened ECM gels exhibited hallmarks of a basal-like phenotype. 
FIGURE 1: Tumorigenic cancer cells exhibit a basal-like phenotype that is fostered by ECM stiffness and EMT. 
(a) Schematic of the 3D collagen bioreactor. Collagen I hydrogels are made in a media reservoir as described previously 
(Cassereau et al., 2015), and the application of 10% strain leads to an increase in effective gel stiffness from 0.5 to 2.5 
kPa. (b) SEM images of representative 2.5 mg/ml collagen hydrogels in strained and unstrained conditions. Porosity 
and fiber orientation are unaltered at 10% strain; increased stiffness may reflect fiber bundling. Scale bar, 2 µm. (c) A 3D 
collagen invasion assay of multicellular spheroids composed of tumorigenic PyMT cells in 2.5 mg/ml 3D collagen gels 
that are unstrained (soft, 0.5 kPa) or strained (stiffened, 2.5 kPa) for 72 h. Tumorigenic PyMT cells recapitulate invasive 
behavior when induced to undergo EMT via treatment with TGFβ. Scale bar, 100 µm. (d) Quantification of invasion 
parameters, total cross-sectional area of spheroid and protrusions, number of protrusions, and number of migrating 
cells normalized to the unstrained, untreated condition. Mean ± SEM (*p < 0.05; ***p < 0.001; >20 cells). 
(e) Immunofluorescence imaging of PyMT cell spheroids in 3D collagen gel stained for β-catenin (green) and DNA (DAPI, 
blue). β-Catenin strongly localizes to cell–cell junctions in cells cultured in soft 3D gels, whereas it is found more diffusely 
within the cytoplasm and nucleus in strain-stiffened gels and TGFβ-treated cells. (f) PyMT cell spheroids in a 3D collagen 
bioreactor express basal epithelial marker K14 at the leader cells when cultured in strain-stiffened gels but maintain 
luminal epithelial K8/18 in the noninvasive core. Induction of EMT via TGFβ treatment also leads to expression of K14 in 
leader cells. (g) Snail transcription visualized by Snail-YFP is up-regulated in leader cells in strain-stiffened gels and 
TGFβ-treated cells. Scale bar, 50 µm (e–g), 10 µm (inset).
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Met1 MECs was due to altered cytoskeletal 
mechanical deformability. To test this idea, 
we used atomic force microscopy (AFM) to 
measure the average cortical elasticity of 
multiple tumor cells plated on 2.7-kPa gels, 
using a 5-µm bead-ligated cantilever with 
multiple indentations across the cellular sur-
face (Figure 3a). The resulting force–inden-
tation curves were fit to a Hertz model to 
estimate an effective elastic modulus (Figure 
3b). Consistent with the notion that tumor 
cells with a higher propensity to metastasize 
are more compliant (Swaminathan et al., 
2011), our AFM measurements revealed 
that the Met1 MECs had a modest but sig-
nificant reduction in effective stiffness com-
pared with the PyMT MECs (Figure 3, c and 
e). Nevertheless, the compliance of the 
EMT-induced PyMT MECs was similar to 
that of the less invasive, untreated PyMT 
MECs (Figure 3, c and e).
Another component of cellular deform-
ability that modulates cell migration through 
a confined microenvironment is nuclear stiff-
ness (Davidson et al., 2014; Harada et al., 
2014; Lautscham et al., 2015; Denais et al., 
2016). Micropipette aspiration experiments 
indicated that there was a modest but statis-
tically significant increase in nuclear deform-
ability in the EMT-induced PyMT MECs 
(Figure 3, f and g). The findings are consis-
tent with the argument that an EMT increases 
nuclear deformability and not cortical stiff-
ness to facilitate cell migration through con-
fined spaces and that this could potentiate 
tumor metastasis.
Tumor cells that migrate more 
efficiently within a confined space are 
more contractile
We next explored whether the enhanced 
invasive phenotype observed by the meta-
static and EMT-induced MECs in the confined channels was associ-
ated with differences in cell–ECM interactions, as measured by the 
degree of cell spreading and/or traction force generation. We used 
traction force microscopy (TFM; Munevar et al., 2001; Paszek et al., 
2005) and compared traction forces exerted by the Met1 and the 
untreated versus EMT-induced PyMT tumor MECs plated on fibro-
nectin-conjugated polyacrylamide (PA) gels with a stiffness cali-
brated to mimic that measured at the invasive front of the malignant 
human and murine mammary tissue stroma (∼2.7 kPa; Munevar 
et al., 2001; Paszek et al., 2005; Laklai et al., 2016). We observed 
that both the TGFβ-treated PyMT MECs and the Met1 MECs gener-
ated higher maximal and total cellular traction forces (Figure 4, a, 
and quantified in b) and higher spread area (unpublished data). We 
also measured higher total and maximal adhesion traction forces 
and enhanced cell spreading in premalignant human MCF10AT 
MECs induced to undergo EMT by treatment with TGFβ as com-
pared with their nontreated controls (Figure 4, c, and quantified in 
d). As expected, TGFβ-treated MCF10ATs also spread progressively 
more on hydrogel surfaces functionalized with increasing concentra-
tions of fibronectin (Supplemental Figure S2).
Swaminathan et al., 2011; McGrail et al., 2015). To test this idea, we 
examined the migration of PyMT tumor MECs through constricted 
microchannels that mimic the confined, stiff microenvironment 
through which metastasizing tumor cells would likely navigate 
(Davidson et al., 2015; Denais et al., 2016; Figure 2). We compared 
cell behaviors after induction of EMT by treatment with TGFβ to that 
of Met1 MECs, a PyMT variant that was previously shown to exhibit 
a propensity to metastasize and yet retain epithelial-like characteris-
tics (Borowsky et al., 2005; Qian et al., 2011). TGFβ-treated PyMT 
MECs migrated more efficiently than untreated MECs through the 
confined channels, as indicated by significantly shorter transit times 
through the constrictions (Figure 2, a and b) and higher percentages 
of cells migrating through constrictions with a cross-sectional area of 
<10 µm2 (Figure 2, c and d). Of importance, Met1 tumor MECs mi-
grated as efficiently as the TGFβ-treated PyMT tumor MECs, imply-
ing that complete EMT is not a prerequisite for efficient migration 
through a confined space.
Because cells with increased mechanical deformability pass 
more easily through confined spaces, we concluded that it was pos-
sible that increased migration of TGFβ-treated PyMT MECs and 
FIGURE 2: Cells with a basal phenotype display enhanced migration through 
microconstrictions. (a) Representative time-lapse image sequences of PyMT cells, PyMT cells 
treated with TGFβ, and Met1 cells migrating through a 1 × 5 µm2 constriction inside a 
microfluidic device. Cells express NLS-GFP to visualize the nucleus. Time displayed as 
hours:minutes. Scale bar, 20 µm. (b) Transit times for cell passage through constrictions ≤10 µm2 
in cross-sectional area, demonstrating that both Met1 cells and PyMT cells treated with TGFβ 
migrate faster through the small constrictions. Mean ± SEM (*p < 0.05, ***p < 0.001, by Kruskal–
Wallis test with Dunn’s multiple comparisons; >70 cells from three independent experiments). 
(c) Representative images of cells inside the microfluidic devices after 48 h of confined 
migration. Fixed cells were stained for F-actin (phalloidin) and DNA (Hoechst 33342). Scale bar, 
50 µm. (d) Incidence of cells successfully migrating through the first row of constrictions within 
36 h relative to the total number of cells inside the microfluidic channels. Error bars represent SE 
of the binomial distribution (*p < 0.05; ***p <0.001; >500 cells by Fisher’s exact test with 
Bonferroni correction).
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Cells that underwent EMT frequently in-
crease α5β1 integrin expression, and fibro-
nectin-ligated α5β1 integrin can significantly 
enhance cell spread area and cell–ECM trac-
tion force (Mierke et al., 2011; Lamouille 
et al., 2014). Consistently, immunoblot and 
fluorescence-activated cell sorting (FACS) 
revealed more total and cell surface α5 
integrin expression in the TGFβ-treated 
MCF10A and PyMT MECs (unpublished 
data). To determine whether higher α5 inte-
grin expression could account for the ob-
served gain in cell spreading and traction 
force generation observed in the TGFβ-
treated MECs, we engineered MCF10A 
MECs to ectopically express higher total α5 
integrin. After confirming more than a two-
fold increase in cell surface α5 integrin ex-
pression by FACS, we assayed for cell 
spread area and traction force compared 
with paired control and TGFβ-treated 
MCF10A MECs. Whereas the MCF10A 
MECs expressing higher levels of α5 integrin 
spread more and exerted higher traction 
force in response to a fibronectin gel, the 
magnitude of the increase was significantly 
lower than that after induction of EMT by 
TGFβ treatment (Supplemental Figure S3).
In summary, these findings suggest that 
in addition to an increase in nuclear de-
formability, there may also be an associa-
tion between the ability of cells to exert 
higher cell–ECM traction forces and their 
ability to migrate more efficiently through a 
confined microenvironment. The data also 
argue that this phenotype cannot be solely 
explained by differences in integrin het-
erodimer expression.
Motor-clutch model of cellular traction 
predicts higher force and cell spread 
area for cells that have an enhanced 
ability to migrate within a confined 
space
We next used computational modeling to 
explore the interplay between cell adhesion 
and cell-generated traction forces exerted 
on compliant substrates. We first modified 
an existing computational motor-clutch 
model of cellular traction generation on 
compliant substrates (Chan and Odde, 
2008). In this model, myosin motors slide an 
F-actin bundle and transmit forces to a 
compliant substrate through physical exten-
sion of molecular “clutch” molecules that 
FIGURE 3: Cells with a basal phenotype are mechanically more compliant. (a) Schematic of AFM 
used to measure effective cell stiffness. Cells are seeded on a 2.7-kPa PA gel conjugated with 
fibronectin and indented using a 2.5-µm beaded tip on the AFM cantilever. (b) Hertz model and 
parameters used to estimate elasticity from a bead contacting a flat plane. (c) Representative 
example surface plots of elasticity for PyMT, TGFβ-treated PyMT, and Met1 cells, showing 
elasticity as function of cell topology. (d) Representative force–indentation curves for a given 
pixel in the surface map, showing the extension and retraction of the cantilever. The Hertz 
model is fit to these data to extract an effective cell elasticity. (e) Quantification of cell 
indentation stiffness for tumorigenic PyMT cells, with and without TGFβ treatment, and 
metastatic Met1 cells. Met1 cells are modestly softer on average than PyMT cells, with TGFβ 
treatment not eliciting a statistically significant response. Mean ± SEM (*p < 0.05; >15 cells). 
(f) Micropipette aspiration of PyMT and TGFβ-treated PyMT cells showing the deformation 
of the nucleus over time. Cell nuclei were visualized by staining DNA with Hoechst 
33342. (g) Compiled nuclear protrusion 
length (ΔL) as a function of time, indicating 
some nuclear softening in response to TGFβ 
treatment. Mean ± SEM (>120 cells from 
three independent experiments). Scale bar, 
20 µm.
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MCF10As). By contrast, many cell types remain well spread and 
generate large traction forces even on stiff substrates (Ghibaudo 
et al., 2008; Elosegui-Artola et al., 2014, 2016). We developed a 
modified motor-clutch model that includes force-dependent recruit-
ment of adhesion components in response to substrate stiffness, 
similar to recently proposed models (Elosegui-Artola et al., 2014, 
2016). Briefly, we incorporated a clutch recruitment feedback rate 
(kadd), which is proportional to the number of clutches experiencing 
force above a threshold (Fthreshold), as well as a maximum number of 
clutches available to be recruited (nclutch,max; see the Supplemental 
Material for model description). By varying key parameters within 
the feedback response (in particular, kadd), we recapitulate varying 
degrees of reinforcement on stiff substrates, with higher reinforce-
ment values (kadd = 0.1–1 s−1), yielding a monotonic trend (Supple-
mental Figure S4). Hence our PA gel results alone did not provide 
enough information to distinguish between the two models––either 
TGFβ-treated cells have a higher optimum stiffness due to increased 
motor and clutch number, or our results are consistent with engag-
ing adhesion reinforcement on stiff substrates.
Cells with a basal-like phenotype exert higher 
integrin-dependent force
To explore the model predictions further, we tested whether the in-
creased overall cellular traction forces observed in Met1 and TGFβ-
treated PyMT and MCF10A MECs translated into an increase in 
molecular forces at the level of individual adhesion complexes. To 
do so, we employed molecular tension sensors (MTSs), which report 
the forces exerted on integrin molecules in living cells (Morimatsu 
et al., 2013, 2015; Chang et al., 2016). Briefly, this technique incor-
porates an elastic protein spring flanked by two fluorophores that 
form a FRET pair (Figure 6a). The MTSs have an integrin-recognition 
domain containing the linear RGD tripeptide, which binds fibronec-
tin-binding integrins. When cells adhere specifically via their integ-
rins to an MTS-coated substrate, tension on individual sensors 
causes the elastic protein to stretch and the fluorophores to move 
transiently engage the actin filament (Figure 5a). The model re-
vealed that efficient force transmission depends on the number and 
biophysical properties of the motors and clutches, clutch binding 
and force-dependent unbinding rates, and substrate mechanical 
properties (Figure 5b; Bangasser et al., 2013). Maximal force trans-
mission occurs at an “optimum” substrate stiffness, whereas clutch 
unbinding increases on softer or stiffer substrates, leading to ineffi-
cient force transmission (Bangasser et al., 2013). Actin retrograde 
flow is biphasic and inversely correlated with traction force, and a 
leading-edge protrusion rate can be used as a proxy for spread 
area, defined by the difference between protrusion and retrograde 
flow (Chaudhuri et al., 2015).
Simulated cells with larger numbers of both myosin II motors and 
integrin-mediated adhesion clutches are better spread and gener-
ate larger tractions on surfaces with increasing stiffness but then go 
through a maximum so that at even higher stiffness, area and force 
are decreased (Figure 5, c and d). The prediction of increasing area 
and force is consistent with the larger adhesion sizes and increased 
traction generation observed for Met1 MECs and TGFβ-treated 
PyMT and MCF10AT MECs relative to untreated PyMT and MC-
F10AT cells (Paszek et al., 2005), at least below the optimal stiffness. 
Within the stiffness range of ∼0.1–10 kPa, our results are consistent 
with nontransformed MECs employing a “weak clutch” regime. In 
this regime, an imbalance of contractile force and clutch number 
results in a failure to spread and low traction forces that modestly 
increase near disease-level stiffness. On addition of TGFβ and in-
duction of an EMT phenotype, the simulated MECs express larger 
numbers of both motors and integrin-mediated adhesions and shift 
to a “balanced motor-clutch” regime in which the clutch strength 
matches that of the motors, resulting in slower actin flow, enhanced 
cell spreading, and higher traction forces (Figure 5, c and d).
As previously described (Chan and Odde, 2008; Bangasser 
et al., 2013), the motor-clutch model predicts a decrease in cell 
spread area and traction force at a substrate stiffness extending 
beyond an optimum stiffness (here ∼10 kPa for TGFβ-treated 
FIGURE 4: Cells with a basal phenotype exert higher traction forces. (a) PyMT and Met1 cells were seeded on 2.7-kPa 
PA gels conjugated with fibronectin and embedded with fluorescent beads for TFM. The displacement fields reflect the 
relative positions of beads before and after cell lysis. At a substrate stiffness comparable to that of tumor ECM 
(∼2.7 kPa), Met1 cells are more spread and exert more traction forces on the substrate. Induction of EMT in PyMT cells 
by treatment with TGFβ recapitulates the increase in traction forces observed with Met1 cells, with total traction force 
even greater than for the Met1 cells. (b) Quantification of cell traction parameters. Metastatic cells have significantly 
increased total cellular and maximum traction forces. Mean ± SEM (*p < 0.05; >5 cells). (c) TFM of MCF10ATs. Cells 
that undergo TGFβ-induced EMT exert higher traction forces than untreated cells. (d) Quantification of cell traction 
parameters. TGFβ-treated MCF10ATs have significantly higher traction forces. Mean ± SEM (*p < 0.05; >5 cells). 
Scale bar, 20 µm (a, c).
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with the TFM data (Figure 4). In addition, both the Met1 MECs and 
the TGFβ-treated PyMT tumor MECs exhibited a modest but statis-
tically significant increase in the average force per MTS sensor 
(Figure 6, c, and quantified in d). This integrin-force phenotype ap-
pears to be conserved: MCF10As that had undergone a TGFβ-
induced EMT also spread more, assembled larger adhesions, gen-
erated higher total tractions as measured using MTSs, and exhibited 
a modest but consistent increase in the force per MTS compared 
farther apart, yielding a decreased fluorescence resonance energy 
transfer (FRET) signal. An average force exerted on an ensemble of 
sensors within a given pixel is then calculated using a previously 
determined calibration curve (Grashoff et al., 2010) modified to in-
corporate the specific fluorophores used in these studies (Figure 6b).
Using this approach, we found that both the TGFβ-treated PyMT 
MECs and the metastatic Met1 MECs generated higher total forces 
at their integrins than did the untreated PyMT MECs, consistent 
FIGURE 5: Motor-clutch model of cellular traction predicts higher force and spread area for cells with a basal 
phenotype. (a) Motor-clutch model of cell traction, including myosin contractility, actin assembly/treadmilling/
disassembly, clutches (linear elastic springs) with constant kon and variable koff rates (dependent on clutch strain, xclutch), 
and a linear elastic compliant substrate. (b) Parameter descriptions and values used in motor-clutch simulations. 
(c) Model predictions of traction force calculated from the results of the simulation. Increasing number of motors and 
clutches leads to an increase in traction force with substrate stiffness and shifts the peak traction to a higher stiffness. 
(d) Model predictions of cell adhesion area that is extrapolated from the length of assembled filaments, which in turn 
depends on the number of motors and clutches. (e) TFM of MCF10A cells with and without TGFβ treatment seeded on 
PA gels of varying stiffness. Cell spread area was quantified from bright-field images, average stress was calculated from 
the displacement fields, and total force was quantified by multiplying average traction stress by the spread area of the 
cell (>10 cells). The total force values represent the sum of individual pixel forces underneath the cell body as a whole 
(average stress times spread area). Scale bar, 20 µm.
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mental Figure S5), consistent with cells adhering to surfaces that are 
stiffer than their optimal stiffness (Bangasser et al., 2013). In addi-
tion, whereas the increased force per bond is statistically significant, 
it is relatively modest compared with the increase in overall traction 
force (Figure 6, c–f), implying that the number of motors and 
clutches both increased. Therefore we conclude that the results are 
consistent with a model in which EMT transition induces an increase 
in both motors and clutches while also shifting from a “weak clutch” 
regime to “balanced motor-clutch” regime (as in Figure 5, c and d) 
but are inconsistent with a model that relies entirely on a force-
feedback reinforcement mechanism (as in Supplemental Figure S4, 
c and d).
with untreated MCF10A MECs (Figure 6, e, and quantified in f). 
Note that the forces reported in Figure 6 are calculated specifically 
within adhesions; analyzing the MTS sensor data in a similar manner 
as the TFM data (namely, by including all pixels underneath the cell 
body) yields similar magnitudes of total force between the two 
techniques (Supplemental Figure S5; Chang et al., 2016). Because 
the MTS substrates are effectively much stiffer than PA gels, we 
used this to test the reinforcement-model prediction that total trac-
tion forces and spread areas for TGFβ-treated cells remain uniformly 
high on stiff substrates. Of interest, contrary to this prediction, 
TGFβ-treated cells show lower traction forces and reduced spread 
area on the MTS substrates compared with 13.8-kPa gels (Supple-
FIGURE 6: Cells with a basal phenotype exert higher integrin-dependent force. (a) Schematic of integrin MTSs. 
(b) FRET efficiency is converted into force using a calibration curve previously determined (Grashoff et al., 2010) and 
modified for the fluorescent dyes used here. (c) When seeded on a coverslip densely coated with MTSs, Met1 cells and 
TGFβ-treated PyMT cells spread more readily and generate higher integrin-mediated forces than untreated PyMT cells. 
(d) Quantification of the total force and average force per integrin MTS, which are both higher for Met1 than with PyMT 
cells. TGFβ treatment of PyMT cells resulted in an increase in cell spread area (unpublished data), total integrin-
mediated force per cell, and average force per MTS, similar to the values measured for Met1 cells (***p < 0.001; 
>15 cells by the Wilcoxon rank sum test). Box-and-whisker plots display the median (red), 25th and 75th percentiles 
(bottom and top edges of the box, respectively), and the most extreme data points not considered outliers (edge of 
whiskers). (e) Integrin MTS measurements for MCF10A cells treated with TGFβ. (f) There is an increase in total force and 
average force for the TGFβ-treated MCF10As compared with the untreated ones (***p < 0.001; >15 cells by the 
Wilcoxon rank sum test). In d and f, the total force values represent the sum of individual pixel forces specifically within 
segmented adhesions. Scale bar, 10 µm (c, e).
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adhesions in epithelial MCF10AT MECs and compared our findings 
to those measured in MECs that had been induced to undergo an 
EMT by TGFβ treatment. We conducted live-cell imaging of focal 
adhesion dynamics using paxillin-mEmerald as a proxy adhesion 
marker in live cells (Figure 7a). Consistent with our traction force 
data and the model predictions, we noted that the stability of the 
integrin adhesions was increased in the TGFβ-treated MCF10AT 
MECs, as evidenced by slower adhesion turnover (Figure 7b). To 
explore whether differences in adhesion lifetime reflected an al-
tered adhesion microstructure, we performed superresolution mi-
croscopy on cellular paxillin–enhanced green fluorescent protein 
(eGFP) using Bayesian analysis of bleaching and blinking (3B), which 
uses the fluctuations in the fluorophore intensities to infer molecular 
localization at subpixel resolutions (Cox et al., 2011). Whereas adhe-
sions in MCF10AT MECs were roughly circular in aspect, the adhe-
sions assembled in TGFβ-treated MCF10AT MECs were elongated 
and featured well-developed linear structures (possibly templated 
by actin bundles; Figure 7, c and d), similar to the adhesions 
In sum, these data indicate that tumor MECs with an elevated 
propensity to metastasize (here, Met1) exert higher traction forces 
than less metastatic but malignant MECs (here, PyMT), due primarily 
to an increase in adhesion size, but also to an increase in the aver-
age force per integrin. This phenotype is shared by MECs that have 
undergone a TGFβ-induced EMT and should therefore also be reca-
pitulated in the basal-like tumor MECs encountering a stiffened 
ECM (Figure 1, e–g). Indeed, when considered with the behavior of 
MECs invading into 3D, stiffened, confined ECMs or within micro-
channels (Figures 1 and 2), these findings suggest that tumor MECs 
that assemble larger adhesions and exert higher integrin-generated 
forces may be able to migrate more efficiently in confined 
microenvironments.
The integrin adhesions in cells with a basal-like phenotype 
are more stable and elongated
To clarify the molecular origins of the increased force per integrin 
within adhesions, we examined the organization and stability of the 
FIGURE 7: TGFβ-induced EMT alters adhesion organization and stability. (a) Live-cell imaging of paxillin-mEmerald and 
tensin-mCherry to visualize focal adhesion turnover in MCF10AT cells with and without TGFβ treatment. Top row: 
control, bottom row: TGFβ-treated. Scale bar, 10 µm (main image), 1 µm (inset). (b) Cumulative distributions of adhesion 
lifetimes. Inset, quantification of mean adhesion lifetime; mean ± SEM (***p < 0.001; >150 adhesions from five cells 
total). (c) Focal adhesion microstructure of MCF10AT seeded on MTSs overexpressing paxillin-eGFP and imaged with 
TIRF and 3B superresolution microscopy. Scale bar, 3 µm (main image), 1 µm (zoom). (d) Quantification of mean adhesion 
length of MCF10AT cells. TGFβ-treated cells have significantly longer adhesions; mean ± SEM (***p < 0.001; 
>100 adhesions from five cells). (e) Tensin-positive fibrillar adhesion formation in MCF10AT overexpressing paxillin-
mEmerald and tensin-mCherry. Scale bar, 3 µm. (f) Quantification of the spatial colocalization between tensin and paxillin 
in adhesions. TGFβ-treated cells have significantly more paxillin-tensin colocalization (*p < 0.05; >10 cells). Pearson’s 
correlation was calculated based on pixels within the focal adhesion areas. (g) Paxillin-mEmerald (N-terminal) axial 
position in focal adhesions in MCF10As measured with SAIM. Paxillin position is plotted as the relative axial distance 
from the silicon wafer coated with fibronectin. Scale bar, 5 µm. (h) SAIM axial height measurements of adhesion proteins 
tagged with fluorescent proteins in MCF10As with and without TGFβ treatment. Paxillin is the only protein to 
significantly change axial position >10 nm, suggesting that the position of paxillin moves relative to that of the adhesion 
as a whole. (i) Quantification of paxillin-GFP axial position in MCF10As with and without TGFβ treatment. Paxillin in 
treated cells is located at a significantly higher axial nanoscale position (*p < 0.05; >10 cells). (j) Representative images 
of the axial position of paxillin-mEmerald (N-terminal) in focal adhesions in PyMT and Met1 cells. Scale bar, 5 µm.
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ized. PINCH forms a complex with integrin-linked kinase (ILK) and 
α-parvin and interacts with paxillin at focal adhesions (Legate et al., 
2006), and knockout of PINCH suppresses migration and vinculin 
localization to adhesions (Gonzalez-Nieves et al., 2013). Consistent 
with observations that ILK modulates breast tumor aggression and 
metastasis in vivo and has been linked to an EMT phenotype (White 
et al., 2001; Persad and Dedhar, 2003; Hannigan et al., 2005), we 
observed ILK enrichment at paxillin adhesions in MCF10A MECs 
that had been induced to undergo EMT by TGFβ treatment (Figure 
8d). Immunostaining also revealed ILK localized to the paxillin adhe-
sions in the PyMT tumor MECs after TGFβ treatment and in the 
PyMT tumor MECs interacting with a stiff ECM compared with those 
plated on a soft ECM (Figure 8, e and f). Of importance, immunoblot 
analysis showed that overall levels of total paxillin and phosphory-
lated paxillin, as well as of ILK, remained largely unchanged after 
TGFβ treatment (Supplemental Figure S8a). Thus the enhanced as-
sociation of ILK proximal to paxillin in adhesions in TGFβ-treated 
cells was not the result of increased ILK expression. Further, abro-
gating myosin-related contractility reduced the association of ILK to 
paxillin-rich adhesions, indicating that the enhanced molecular in-
teractions to paxillin were favored under conditions of elevated ac-
tomyosin-generated force (Supplemental Figure S8, b and c; Schiller 
et al., 2013). These findings imply that the more prominent, longer-
lasting integrin adhesions fostered by the elevated traction force in 
the metastatic and basal-like MECs facilitated the recruitment of a 
suite of paxillin-associated proteins that fosters tumor cell invasion 
within a dense and stiffened ECM.
Phosphorylation of paxillin by Src family kinases is elevated 
in the mammary tumor cells with a basal-like phenotype and 
enhances invasion within a stiff 3D ECM
Tumor cell invasion requires integrin adhesion turnover stimulated 
by the phosphorylation of key adhesion plaque proteins, including 
paxillin (Tumbarello et al., 2005). Immunofluorescence analysis re-
vealed that phosphorylation of paxillin (tyrosine 31) was elevated in 
the TGFβ-treated MCF10A MECs (Figure 9a). Paxillin tyrosine 31 
and 118 phosphorylation was also enhanced in the PyMT MECs in-
duced to undergo EMT by TGFβ treatment and in the invasive Met1 
tumor MECs (Figure 9b and Supplemental Figure S9). We also de-
tected strong phosphopaxillin staining at paxillin adhesions in basal-
like leader PyMT tumor MECs invading into the 3D collagen/fibro-
nectin gels in response to ECM stiffening (Figure 9c). Critically, 
preventing paxillin phosphorylation through ectopic expression of a 
nonphosphorylatable paxillin mutated at tyrosine residues 31 and 
118 to phenylalanine (paxillinY31/118F) to hinder adhesion turnover 
(Webb et al., 2004; Pasapera et al., 2010; Plotnikov et al., 2012) in-
hibited Met1 tumor cell invasion into a 3D stiffened collagen gel 
(Figure 9, d, and quantified in e). Paxillin phosphorylation is medi-
ated predominantly by Src family kinases (Schaller, 2001), and our 
Bio-ID assay revealed that GIT2, a Src substrate, was enriched proxi-
mal to paxillin in TGFβ-treated MCF10A MECs (enrichment factor, 
∼4; Yu et al., 2009, 2010; Bianchi-Smiraglia et al., 2013; Figure 8b). 
We therefore examined whether Src activity was critical for the ele-
vated paxillin phosphorylation and enhanced invasive phenotype of 
the Met1 MECs in response to a stiffened 3D collagen/fibronectin in 
the bioreactor. Consistently, treatment of the metastatic Met1 and 
PyMT multicellular spheroids with the Abl/Src inhibitor dasatinib (20 
nM) reduced paxillin phosphorylation and significantly decreased 
invasion of the tumor cell within the stiffened collagen/fibronectin 
hydrogel (Figure 9f).
The clinical relevance of these findings was investigated by 
analysis of the Cancer Genome Atlas (TCGA) data set and patient 
observed in fibroblasts and other mesenchymal cells (Morimatsu 
et al., 2015).
Alterations in adhesion stability and structure plausibly reflect 
differences in molecular composition (Zamir et al., 1999; Yoshigi 
et al., 2005; Wolfenson et al., 2013). To investigate this possibility, 
we assayed the colocalization of tensin, a marker for fibrillar adhe-
sions, with paxillin in MCF10AT MECs with and without TGFβ treat-
ment (Figure 7e). Pearson’s correlation coefficient between paxillin 
and tensin was significantly higher for the TGFβ-treated MECs, sug-
gesting that the differences in integrin adhesion size and shape 
were mirrored by changes in molecular composition (Figure 7f). To 
further probe potential differences in molecular architecture, we 
performed scanning angle interference microscopy (SAIM; Paszek 
et al., 2012; DuFort and Paszek, 2014) to measure the axial position 
of known adhesion proteins (Figure 7, g–i). We found that focal ad-
hesion kinase (FAK), talin, vinculin, and zyxin retained the same rela-
tive axial positions in both MCF10A and TGFβ-treated MCF10As 
(referenced to the coverslip; Figure 7 h). Intriguingly, the position of 
paxillin relative to the silicon wafer substrate increased from an aver-
age of ∼50 nm in the epithelial MCF10As to ∼65 nm in the TGFβ-
treated, EMT-induced MCF10As (Figure 7i). SAIM imaging revealed 
a similar qualitative shift in paxillin height between the epithelial 
PyMT tumor MECs and their TGFβ-treated EMT-induced counter-
parts (Figure 7j). Of importance, paxillin phosphorylation alone 
could not account for the shift in molecular height observed after 
EMT induction, as revealed by studies in which a nonphosphorylat-
able paxillin (mutated at tyrosine residues 31 and 118 to phenylala-
nine; paxillinY31/118F) localized at the same height as a wild-type pax-
illin in paxillin-null mouse fibroblasts transfected with equal 
quantities of transgene (Supplemental Figure S6). These findings 
suggest that MECs that recapitulate a basal-like phenotype or that 
underwent a mesenchymal transition not only exert more cellular–
ECM integrin traction forces, but also assemble integrin adhesions 
that may be more stable and acquire a distinct cellular and subcel-
lular organization.
Proteomics identifies a protein complex implicated in tumor 
cell invasion and metastasis recruited to integrin adhesions 
in cells with a basal-like phenotype
We next sought to determine whether the differences in integrin 
adhesion force, stability, and cellular and subcellular organization 
observed in the cells with a basal-like phenotype translated into dis-
tinct differences in molecular composition. Given the significant 
height changes we observed in paxillin in the EMT-induced MECs, 
we used a mass spectroscopic proteomics approach termed Bio-ID 
(Roux et al., 2012) to explore whether this was reflected by altered 
molecular interactions. We fused a promiscuous biotin ligase pro-
tein (BirA*) to the N-terminus of paxillin-eGFP and expressed this 
construct in MCF10A MECs treated with vehicle or TGFβ to induce 
an EMT (Figure 8a; Dong et al., 2016). Analogous measurements 
used BirA* fused to eGFP as a control for nonspecific biotinylation. 
Focusing on the consensus list of integrin adhesome proteins (Hor-
ton et al., 2015; Figure 8b), we found that particularly interesting 
new cysteine-histidine-rich protein (PINCH; gene name LIMS1) was 
the most significantly enriched associated protein proximal to paxil-
lin in the TGFβ-treated MCF10A MECs (highly abundant in TGFβ-
treated cells and not present in untreated cells). Intensity correlation 
analysis of immunostained human MCF10A MECs showed that the 
amount of PINCH in paxillin-rich adhesions increased significantly in 
MCF10A MECs after TGFβ treatment (Supplemental Figure S7). In-
deed, even in the epithelial MCF10A MECs that assembled sizeable 
integrin adhesions, PINCH was largely absent or diffusely colocal-
Volume 28 June 1, 2017 High traction forces enhance invasion | 1477 
sion had a significantly higher risk of death (p < 0.02; hazard ratio, 
1.34), whereas high expression of β1 integrin or talin did not as-
sociate with increased patient mortality (Supplemental Figure 
S10). Intriguingly, Src regulates FAK activity, FAK regulates integrin 
adhesion turnover, and FAK critically regulates cancer progression 
and metastasis (Deramaudt et al., 2014; Sulzmaier et al., 2014). 
Evaluation of reverse-phase protein array data derived from 892 
human breast cancer patients further indicated that patients with 
survival (Györffy et al., 2013). Gene expression data analysis 
revealed that patients with invasive breast cancer stratified into 
those with lymph node–positive cancers that had high levels of 
paxillin transcript also had a significantly worse chance of survival 
(p < 0.001; hazard ratio of 1.46 at 10 yr vs. patients with low paxil-
lin levels; Figure 9g). Examination of the mortality hazard ratio for 
breast cancer patients with high gene expression of other integrin 
adhesion proteins also showed that patients with high FAK expres-
FIGURE 8: Proteomics identifies unique proteins recruited to paxillin in the integrin adhesions during EMT. (a) BioID 
technique. A control BirA*-eGFP construct and a BirA*-paxillin-eGFP construct are stably expressed in MCF10A cells, 
which are then treated with TGFβ to induce EMT. BirA*-paxillin-GFP localizes to FAs and biotinylates proteins adjacent 
to paxillin when biotin is added to the medium. Biotinylated proteins are isolated and identified by mass spectrometry. 
(b) Normalized spectral counts for the consensus adhesome were clustered on the basis of an uncentered Pearson 
correlation using Cluster 3.0 and visualized using Java TreeView. From a subgroup of known paxillin interactors, we 
identify GIT2, LIMS1 (PINCH), and vinculin as enriched in TGFβ-treated cells. Black indicates no protein detected in the 
+TGFβ:–TGFβ scale bar, and gray indicates no enrichment relative to the control. (c) Model for potential paxillin 
associations altered in response to TGFβ treatment. PINCH, GIT2, and vinculin localize adjacent to paxillin, and these 
associations are enriched in TGFβ-treated cells. (d–f) Immunofluorescence images of paxillin (green) and ILK (magenta). 
ILK is enriched in paxillin-rich adhesions in (d) MCF10A cells treated with TGFβ and (e) PyMT cells treated with TGFβ. 
Scale bar, 10 µm (main image), 5 µm (inset). (f) Immunofluorescence images of paxillin and ILK in PyMT cells on stiff 
(6 kPa) and soft (0.4 kPa) PA gels coated with fibronectin, showing that stiffness and TGFβ treatment modulate the 
recruitment of ILK to paxillin-rich plaques. Scale bar, 10 µm (main image), 2 µm (inset).
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tute tractable prognostic markers for decreased survival of patients 
with breast cancer. The cell biology studies imply that Src family 
kinase-dependent phosphorylation of paxillin may detect tumor 
cells with an intrinsic or tension-induced basal-like phenotype. 
elevated levels of paxillin also had significantly higher levels of 
phosphorylated Src-416, likely reflecting increased Src activity 
(Figure 9h). Thus the clinical data suggest that elevated total and 
Src family kinase-dependent phosphorylated paxillin may consti-
FIGURE 9: Enhanced paxillin phosphorylation permits invasion in cells with a basal phenotype. (a) Paxillin localization to 
the basal surface in MCF10A cells with and without TGFβ treatment visualized with immunofluorescence staining and TIRF 
imaging of paxillin and phosphorylated paxillin, pPax[31]. Scale bar, 10 µm (main image), 1 µm (inset). (b) Paxillin 
expression in PyMT, Met1, and PyMT + TGFβ visualized with immunofluorescence staining and confocal imaging of 
paxillin and phosphorylated paxillin pPax[31]. Scale bar, 10 µm (main image), 1 µm (inset). (c) Paxillin expression of PyMT 
cell spheroids visualized in soft and stiffened 3D collagen gel. Leader cells in stiffened gel have higher levels of 
phosphorylated paxillin indicated by pPax[31] immunostaining. Scale bar, 20 µm (main image), 10 µm (inset). (d) A 3D 
collagen invasion assay of multicellular spheroids composed of Met1 cells overexpressing either paxillinWT or paxillinY31/118F 
in 2.5 mg/ml 3D collagen gels for 72 h. Scale bar, 100 µm. (e) Quantification of invasion. PaxillinWT overexpression 
significantly increased invasion compared with control or paxillinY31/118F overexpression, as determined by cross-sectional 
area of spheroid and protrusions and single-cell invasion (*p < 0.05; >20 spheroids). (f) A 3D collagen invasion assay of 
multicellular spheroids composed of metastatic Met1 cells treated with dimethyl sulfoxide or 20 nM dasatinib, a Src/Abl 
inhibitor, in 2.5 mg/ml 3D collagen gels for 72 h. Dasatinib addition significantly decreased cell invasion, as determined by 
cross-sectional area and single-cell invasion (*p < 0.05; >15 spheroids). Scale bar, 100 µm. Dasatinib addition decreased 
levels of paxillin phosphorylation visualized by pPax[31] immunofluorescence. Scale bar, 5 µm. (g) Kaplan–Meier survival 
curve of invasive breast cancer patients expressing either high or low levels of paxillin. High paxillin levels are associated 
with a significantly worse chance of survival (p < 0.001; hazard ratio 1.46 at 10 yr). (h) Src phosphorylation levels via RPPA 
in TCGA breast cancer patients separated into control and paxillin–up-regulated groups. Paxillin up-regulation is 
correlated with a significant increase in Src phosphorylation at tyrosine 416 (*p < 0.05; >4200 patients).
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was markedly decreased. Accordingly, our 
findings suggest that metastasis would be 
favored by tumor cells that either adopt or 
temporarily borrow a conserved, “EMT-like” 
or “basal-like” integrin adhesion phenotype 
with higher integrin-mediated traction force 
generation (Figure 10).
EMT has been proposed as a central, 
and even required, process in cancer metas-
tasis (Chaffer and Weinberg, 2011; Tsai 
et al., 2012). Cells in epithelial tissues are 
polarized, nonmigratory, and linked by me-
chanically robust intercellular adhesion 
complexes (Przybyla et al., 2016). An EMT 
offers a conceptually attractive mechanism 
by which carcinoma cells could reverse 
these defining characteristics in order to mi-
grate through surrounding tissues and es-
tablish distant metastases. Furthermore, in-
vading malignant cells often exhibit at least 
some of the molecular hallmarks of EMT—
for example, the expression and engage-
ment of transcription factors such as Twist or 
Snail, which are considered defining fea-
tures of EMT in a developmental context 
(Yilmaz and Christofori, 2009; Przybyla et al., 
2016). However, recent work has challenged 
the centrality of EMT to malignancy. In 
mouse models, distant metastases prefer-
entially formed from multicellular aggre-
gates rather than single cells. Further, me-
tastasizing cells remained linked by robust 
cell–cell adhesions and maintained expres-
sion of E-cadherin, whose loss is classically 
considered a hallmark of EMT (Cheung et al., 2013, 2016). In addi-
tion, cells invading into a 3D ECM from murine mammary tumor 
colonies, as well as human tumor colonies isolated from women with 
aggressive breast tumors, did not undergo a canonical EMT; in-
stead, the leader cells adopted key features of a “basal-like” re-
sponse while maintaining their epithelial phenotype (Nguyen-Ngoc 
et al., 2012; Cheung and Ewald, 2014). More broadly, mesenchymal 
cells—for example, fibroblasts—are not intrinsically tumorigenic, 
and in humans are less likely to become cancerous than cells from 
epithelial tissues (Quail and Joyce, 2013). Our findings are consis-
tent with these observations and imply that tumors cells may merely 
temporarily or permanently exploit basal-like features to facilitate 
their metastasis.
In the context of breast cancer, the perspective that a tumor 
need not undergo a complete EMT to metastasize has led to a re-
vised model in which malignant epithelial cells adopt key features of 
basal-like/partial EMT cells and whose phenotypic characteristics 
may facilitate multicellular invasion into the surrounding tissue. Our 
data showed that an ECM with a stiffness matching that of the breast 
cancer stroma induced the leader PyMT epithelial cells within a tu-
mor colony to adopt characteristics consistent with the “basal-like/
partial EMT” phenotype, including cytokeratin 14 and Snail expres-
sion and partial disassembly of cell–cell adhesions, that was associ-
ated with their invasion into the surrounding matrix as loose cellular 
aggregates extending from the primary colony. The findings illus-
trate how the tissue microenvironment can promote the adoption 
of a presumably transient “basal-like” program that fosters tumor 
cell dissemination without compromising the overall epithelial 
DISCUSSION
In this study, we sought to understand the key cellular biophysical 
properties that endow breast tumor cells with a propensity to me-
tastasize and in particular the ability to invade and migrate through 
confined spaces. We present evidence of underlying similarities be-
tween metastatic breast tumor cells, EMT-induced breast tumor 
cells, and breast tumor cells interacting with a stiffened ECM that 
exhibit a basal-like phenotype. In each of these cases, we found that 
the breast tumor cells assembled large, elongated, “mesenchymal-
like” focal adhesions that exerted markedly higher forces than those 
assembled in analogous cells lines that were predominantly epithe-
lial and less metastatic in nature. Our findings revealed that these 
intrinsic or microenvironment-induced differences in adhesion size 
and force output reflected alterations in adhesion architecture, turn-
over, and molecular composition. Of note, in each of these condi-
tions, the paxillin adhesions in the invasive basal-like tumor cells 
associated with the recruitment of a suite of adhesion plaque pro-
teins, including PINCH and ILK—components of the PINCH/parvin/
ILK complex previously implicated in tumor cell invasion and metas-
tasis (Persad and Dedhar, 2003; Legate et al., 2006). In each of the 
invasive, basal-like cells, the paxillin that was recruited to focal adhe-
sions was highly phosphorylated, a finding that is consistent with the 
notion that integrin adhesion turnover is essential for tumor cell in-
vasion (Deramaudt et al., 2014). Consistently, when the invasive 
breast tumor cells were treated with a broad-spectrum Src family 
kinase inhibitor that is currently used in the clinic to treat cancer, 
paxillin phosphorylation was reduced at focal adhesions, and the 
invasiveness of the metastatic breast tumor cells into a 3D stiff ECM 
FIGURE 10: Mechanistic model. (a) ECM stiffness and induction of EMT enhance metastatic 
behavior, evidenced by increased invasion in 3D collagen matrices, expression of basal epithelial 
markers and Snail transcription in leader cells, and a higher propensity to migrate through small 
constrictions. (b) Adoption of a mesenchymal phenotype results in biophysical properties similar 
to those of basal-like cells, including higher integrin-mediated traction forces and more stable, 
elongated focal adhesions. (c) Axially scaled model of adhesion architecture changes in basal-like 
cells (TGFβ treated), showing the average increase in paxillin height of 15 nm. (d) EMT promotes 
the association of the ILK-PINCH-parvin (IPP) complex, vinculin, and Git2 directly to or in the 
vicinity of paxillin. Paxillin phosphorylation, mediated through kinases such as Src, regulate 
adhesion turnover and cell invasion.
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specification and is proposed to guide osteogenesis and myogen-
esis (Lee et al., 2015; Taylor- Weiner et al., 2015). Our data are thus 
consistent with the general idea that increased traction forces exhib-
ited by prometastatic cancer cells may reflect a selective hijacking of 
one critical aspect of the EMT phenotype.
We present a simple physical model, modified from previous it-
erations (Chan and Odde, 2008; Bangasser et al., 2013; Elosegui-
Artola et al., 2016), that could explain the cell-level changes in adhe-
sion and contractility that facilitate metastasis. A principal prediction 
arising from this model is that both enhanced cell ECM adhesion (an 
increased number of “clutches”) and increased contractility (an in-
creased number of “motors”) are required for the increase in cellular 
traction that accompanies the malignant phenotype. Our experi-
mental measurements of cellular ECM traction and adhesion size, 
architecture, and dynamics are consistent with this general predic-
tion. In particular, our MTS measurements indicated large increases 
in cellular traction forces in all of the breast tumor cell lines with a 
prometastatic or an EMT-like phenotype and revealed that the 
forces were likely transmitted through larger force-producing integ-
rin adhesions. Intriguingly, our data revealed that the average force 
per integrin complex was modestly increased, suggesting that, in 
addition to an increase in clutch number, individual bond properties 
were also altered by addition of TGFβ. For example, the increased 
force per bond could be due to a modest increase in the character-
istic bond force (Fbond) or modest decrease in basal clutch unbind-
ing rate (koff). Higher forces at the single-integrin level may plausibly 
reflect force-mediated “outside-in” signaling to drive clutch and 
motor addition (as in our biophysical model), which would then link 
to integrin-dependent intracellular signaling to drive actomyosin-
dependent cytoskeletal tension. In the case of metastatic tumors, 
which exhibit increased integrin-linked forces and elevated “onco-
gene-dependent” actomyosin contractility, this relationship is pre-
dicted to reset the state of cellular tensional homeostasis to a higher 
level (Paszek and Weaver, 2004; Laklai et al., 2016).
Our data suggest that differences in adhesion properties reflect 
changes in adhesion molecular composition. We found that the 
large, force-producing adhesions assembled in the MECs that had 
undergone an EMT recruited more PINCH and ILK, which comprise 
part of the PINCH/Parvin/ILK complex, which has been strongly im-
plicated in tumor cell invasion and metastasis (Persad and Dedhar, 
2003; Legate et al., 2006). Our findings are also consistent with cell 
studies implicating ILK in an EMT and transgenic mouse work show-
ing that ILK overexpression promotes breast tumor progression, 
whereas its knockdown reduces tumor aggression (White et al., 
2001; Hannigan et al., 2005; Serrano et al., 2012; Pang et al., 2016). 
Thus adoption of the EMT-like adhesion phenotype by tumor cells 
may favor the recruitment of key signaling molecules that facilitate 
tumor cell invasion. Consistently, we found that paxillin displayed a 
pronounced shift in z height relative to the membrane in cells that 
had gone an EMT, suggestive of a differential role in epithelial ver-
sus mesenchymal cells.
Adhesion turnover is required for cell migration and for the 
metastatic dissemination of malignant cells (Friedl and Alexander, 
2011). Consistent with this concept, despite the fact that the mam-
mary tumor cells that had undergone an EMT assembled large, 
distinct focal adhesions and recruited a large repertoire of adhe-
sion plaque proteins, they were also highly dynamic. The integrin 
adhesions formed by the metastatic breast tumor cells, breast tu-
mor cells induced to undergo an EMT, and the basal-like PyMT 
tumor colonies interacting with a stiffened ECM also had elevated 
levels of phosphorylated paxillin, an observation echoing prior re-
ports that paxillin phosphorylation is higher in metastatic cells and 
phenotype (Cheung et al., 2013; Pickup et al., 2013). Our studies 
thus provide a plausible explanation for the seemingly irreconcilable 
multicellular versus EMT phenotype as metastatic promoters. Criti-
cally, our observations suggest that malignant cells can either per-
manently or transiently borrow critical elements of a mesenchymal 
phenotype, notably the ability to exert large tractions on their sur-
rounding ECM that would facilitate their dissemination through con-
fined spaces. Our findings also predict that tumor cells should be 
able to adopt this metastatic adhesion phenotype without surren-
dering essential elements of their epithelial phenotype, such as cell–
cell adhesion, which we and others showed can enhance survival in 
response to chemotherapy and during metastasis and would favor 
their ability to form macroscopic tumors (Weaver et al., 2002; Loess-
ner et al., 2010; Longati et al., 2013).
Metastatic cells that penetrate through confined spaces experi-
ence extensive cell deformation (Doyle et al., 2013; Wolf et al., 
2013). In some studies, biophysical measurements revealed that 
metastatic tumor cells have a lower effective stiffness than their pri-
mary tumor counterparts (Darling et al., 2007; Swaminathan et al., 
2011). A decrease in cell stiffness, believed to be linked to induction 
of an EMT, presumably provides the metastatic cell with a means to 
migrate through confined spaces (Osborne et al., 2014; McGrail 
et al., 2015). In our hands, the prometastatic Met1 and EMT-induced 
PyMT MECs exhibited an enhanced ability to pass through confined 
channels relative to the less metastatic parental PyMT MECs. How-
ever, AFM indentation revealed that this enhanced migratory ability 
did not consistently correlate with an increase in cortical deform-
ability. However, we recognize that the AFM indentation measure-
ments performed in the present studies report cell cortical stiffness, 
whereas the overall elasticity of the cytoskeleton may differ signifi-
cantly. Another important proviso is that alterations in nuclear de-
formability, as we showed, also change after TGFβ treatment–in-
duced EMT, and this elevated compliance may itself significantly 
contribute to the cells’ ability to navigate through constrictions. 
Nevertheless, our findings do suggest that an increase in cytoskel-
etal compliance is not an absolute prerequisite for cell migration 
through a confined microenvironment (Pathak and Kumar, 2012; 
Charras and Sahai, 2014; Lautscham et al., 2015). Instead, our stud-
ies suggest that an obvious likely contributor to the ability of cells to 
pass through constrictions is the ability of the disseminating cells to 
generate substantial tractions at their ECM adhesions. In short, our 
observations are consistent with the idea that cells that have a 
higher propensity to metastasize are more contractile, and yet their 
nucleus is more deformable. Thus cell contractility and stiffness are 
not synonymous, particularly in a diseased state in which cells adopt 
different phenotypes and/or behaviors than during normal physio-
logical function.
More broadly, generation of integrin–ECM traction by cancer 
cells is linked to matrix stiffening and matrix remodeling (Paszek 
et al., 2005; Schedin and Keely, 2011; Jansen et al., 2013; Rubashkin 
et al., 2014a), both of which are believed to contribute to metastasis 
(Lu et al., 2012; Pickup et al., 2014). Consistently, prior studies cor-
related increased traction stresses with metastatic potential, albeit 
using a variety of cancer cell types with diverse origins that may or 
may not reflect a true acquisition of a metastatic phenotype 
(Kraning-Rush et al., 2012). Here we found that the Met1 MECs and 
EMT-induced PyMT MECs increased their traction forces relative to 
the parental PyMT MECs, findings that are consistent with results 
reported here and elsewhere showing that a stiff ECM increases 
cellular traction force and fosters tumor cell metastasis (Paszek et al., 
2005; Kraning-Rush et al., 2012; Pickup et al., 2013). Of interest, an 
increase in cellular traction force is required for endoderm 
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The modified BirA* was then cloned in-frame with full-length paxil-
lin-eGFP (Addgene plasmid 15233) at the N-terminus, such that the 
final construct had 3xmyc-BirA*-N22-paxillin-eGFP in order from N- 
to C-terminus. A fusion of mEmerald to the C-terminus of myc-
tagged BirA* served as a control.
Transient transfection was performed using either Lipofectamine 
2000 reagent or the Lonza Nucleofector Kit V, with program T024 
for all epithelial cell lines and U024 for other cell lines. Recombinant 
lentivirus of the tet-promoter rtTA (neo) was prepared by transient 
transfection into HEK-293T cells, generating lentivirus titer used to 
transduce cells, as previously described (Rubashkin et al., 2014a). 
Target cells constitutively expressing the synthetic reverse Tet tran-
scriptional transactivator rtTAs-M2 were prepared by transduction 
with a G418 selectable lentiviral vector. These cells were transiently 
transfected with pPB puro Tet constructs and an expression con-
struct for a hyperactive piggyBac transposase pCMV-HAhyPBase 
(generous gift of Allan Bradley, The Wellcome Trust Sanger Institute; 
Yusa et al., 2011).
Stable cell lines were selected in 200 ng/ml G418, 380 ng/ml 
hygromycin, or 1 µg/ml puromycin and sorted on a FACSAria II cell 
sorter (BD Biosciences) for fluorescent protein expression. Expres-
sion of inducible protein-encoding gene was induced with 200 ng/
ml doxycycline in growth medium for 1 d before experimentation.
Hydrogel and substrate preparation
Collagen gels were fabricated by diluting 2.5 mg/ml acid-solubi-
lized rat tail collagen (BD) in 1:1 DMEM-F12 (Invitrogen), neutraliz-
ing to pH 7.4 with 1 M NaOH. For 3D collagen gels, a base layer of 
∼250-µm thickness was cast at 37°C for 30 min, followed by a sec-
ond layer that included the cell suspension, which was also allowed 
to solidify over 30 min. Two-dimensional (2D) PA gels (height 
∼200 µm) were fabricated by varying the acrylamide and cross-linker 
concentration and assessing stiffness using either ATM or a shear 
rheometer (Johnson et al., 2007). Red fluorescent beads (100 nm; 
Invitrogen) were incorporated in the PA gels at 1:300 dilution rela-
tive to the manufacturer’s concentration and centrifuged at 200 RCF 
to move the beads to the top surface of the gels for TFM. PA gels 
were functionalized with 10 µg/ml human fibronectin (Millipore) as 
described (Lakins et al., 2012).
N-type [100]-orientation silicon wafers with 1933-nm silicon ox-
ide (1 cm x 1 cm; Addison Engineering) and borosilicate glass cov-
erslips (∼150 µm thick) were cleaned by successive sonication in 
acetone and 1 M KOH (20 min), followed by chemical activation with 
silane (0.5% (3-aminopropyl)trimethoxysilane)) and glutaraldehyde 
(0.5% in water). The substrates were then ultraviolet- and ethanol-
sterilized and incubated overnight (4°C) in extracellular matrix 
(human fibronectin, 10 µg/ml; Millipore). Before use, substrates 
were washed in phosphate-buffered saline (PBS; five times; pH 7.4), 
treated with sodium borohydride (20 mg/ml), and washed with PBS. 
SAIM calibration wafers were prepared by sonicating carboxylate-
modified red fluorescent spheres (100 nm; Invitrogen), following by 
bead deposition (5 × 108 beads/ml) in NaCl (100 mM) PBS solution 
as described (Paszek et al., 2012).
Immunofluorescence
Cells were cultured on various substrates overnight and then fixed 
with 4% paraformaldehyde (PFA; 2D: 20 min, room temperature; 
3D: overnight, 4°C) and stained as described (Levental et al., 2009). 
Primary antibodies against paxillin (5H11, Millipore; 610620, BD; 
P1093, Sigma-Aldrich; 32084, Abcam), phospho–paxillin-tyrosine 
118 (44-722G, Life Technologies; 2541, Cell Signaling), phospho–
paxillin-tyrosine 31 (44-720F, Life Technologies), vinculin (hVIN-1, 
in cells treated with TGFβ (Tumbarello et al., 2005). Phosphoryla-
tion of paxillin by Src family kinases acts to induce both adhesion 
growth and disassembly and hence serves as a master regulator of 
adhesion stability (Turner, 2000; Webb et al., 2004; Zaidel-Bar 
et al., 2006; Wolfenson et al., 2011). We found that tumor cells 
interacting with a stiffened 3D ECM also exhibited higher levels of 
phosphorylated paxillin at their integrin adhesions, which may re-
flect an adaptation of the cells’ inherent sensing response to a soft 
substrate (Plotnikov et al., 2012). Regardless, we showed that 
blocking paxillin phosphorylation either by point mutagenesis or 
by adding a small-molecule inhibitor of a Src family kinase used in 
the clinic blocked the 3D invasion of Met1 MECs. Moreover, epi-
demiological data indicate that high paxillin expression correlates 
with decreased patient survival, and phospho-array data show that 
elevated tumor paxillin associates with high Src kinase levels and 
activity. Thus alterations in adhesion structure and dynamics may 
be directly linked to patient outcome, and assessment of integrin 
adhesion composition may constitute an untapped prognostic 
indicator.
MATERIALS AND METHODS
Cell culture and reagents
MECs, including nonmalignant MCF10A (American Type Culture 
Collection; verified by epithelial cellular morphology in two dimen-
sions, ability to form hollow, polarized acini in 3D rBM gels, and ex-
pression of epithelial markers, including E-cadherin and cytokeratins 
8 and 14) and premalignant Ha-Ras–transformed MCF10AT (Karma-
nos Cancer Institute; verified by epithelial cell morphology in two 
dimensions) were cultured as described (Rubashkin et al., 2014a). 
Tumorigenic MEC lines PyMT Flox3 and metastatic Met1 (kind gift 
of the Moses laboratory, Vanderbilt University) were cultured as de-
scribed previously (Borowsky et al., 2005). 
The 3D multicellular spheroids were generated in rBM (Matrigel; 
Corning) suspension cultures as described (Rubashkin et al., 2014a). 
MCF10A and Met1 MECs were flow sorted on a FACSAria II cell 
sorter (BD Biosciences) via primary and secondary antibody staining 
for top ∼20% or bottom ∼20% expression of α5 integrin, β1 integrin, 
or αvβ3 integrin. The chemokine human TGFβ at 10 nM (PeproTech 
or Sigma-Aldrich) was used for 3 d to induce mesenchymal behavior. 
The small-molecule inhibitor dasatinib was used at 20 nM (Cayman 
Chemical).
Expression constructs
Transient plasmid constructs included Clontech vectors containing N- 
and C-terminus–tagged vinculin-mEmerald, paxillin-mCherry, paxil-
lin-mEmerald, farnesyl-mEmerald, farnesyl-mCherry, FAK-mEmerald, 
Talin-mEmerald, Talin-mCherry, Zyxin-mEmerald, Tensin-mEmerald, 
and Tensin-mCherry. Expression constructs were provided by the 
Davidson Lab. Piggybac transposable plasmids containing eGFP-
paxillin and eGFP-paxillinY31/118F were synthesized and cloned (Epoch 
Life Science, Sugar Land, TX) into BsaI-digested pHULK piggyBac 
Mammalian Expression Vector–CometGFP (DNA 2.0).
Stable cell lines inducibly expressing BirA*-paxillin derivatives 
were prepared using a custom-built PiggyBac transposable vector, 
pPB puro Tet. Briefly, pPB puro Tet includes the hepatamerized tet-
racycline (tet) operator minimal CMV promoter, which drives expres-
sion of a transgene with a 5’ chimeric intron and polyadenylation 
signal derived from bovine growth hormone. pPB puro Tet also in-
cludes an expression cassette for puromycin selection in reverse 
orientation. BirA* (Roux et al., 2012) was modified with three tan-
dem repeats of the myc 9E10 epitope at the N-terminus and a 22–
amino acid, C-terminal glycine- and serine-rich flexible linker (N22). 
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2016). Briefly, the migration devices contain 5-µm-tall channels with 
constrictions ranging from 1 to 15 µm in width. Migration channels 
are flanked on either side by two unconfined regions with a height 
of 250 µm (Davidson et al., 2015). Molds of the migration devices 
were generated using two-layered SU-8 photolithography as de-
scribed previously (Davidson et al., 2014). Replicas of the molds 
were made from a two-component Sylgard 184 polydimethylsilox-
ane (PDMS) kit (Dow Corning) using the (1:10) manufacturer’s recipe 
and cured for 2 h at 65°C. After curing, devices were cut to size, and 
holes were punched for cell-seeding ports and media reservoirs. A 
plasma cleaner (Harrick Plasma) was used to covalently bind micro-
fluidic devices to glass coverslips that had been soaked in 0.2 M HCl 
overnight, rinsed with water and isopropanol, and dried. To improve 
adhesion after plasma cleaning, the completed devices were heated 
on a hot plate at 95°C for 5 min before sterilization with 70% etha-
nol. Devices were rinsed and treated with 20 µg/ml fibronectin (Mil-
lipore) overnight at 4°C. After incubation, the devices were rinsed 
with 1× PBS and cell culture medium. For the experiments, 30,000 
cells/device were loaded into each device and allowed to attach 
overnight. Experiments were conducted with a 0–10% fetal bovine 
serum (FBS) gradient across the constrictions to stimulate directed 
migration, with cell medium supplemented with 25 mM HEPES. De-
vices were sealed with a glass coverslip to minimize evaporation and 
placed on a temperature-controlled stage (37°C) of an inverted 
Zeiss Observer Z1 microscope equipped with a CCD camera (Pho-
tometrics CoolSNAP KINO) and a motorized stage. Images for time-
lapse sequences were acquired every 10 min for at least 12 h 
through a 20× air objective (0.8 NA) using ZEN software (Zeiss).
Images were analyzed using ZEN and ImageJ. Cell transit times 
through constrictions were measured for individual cells based on 
time-lapse sequences, with the starting point defined by the frame 
showing the first signs of nuclear deformation as a cell entered into 
a constriction, and the ending point defined by the frame at which 
the cell had migrated through the constriction and the nucleus was 
no longer “pinched.” The fraction of cells that had passed through 
the first row of constrictions was determined using the final frame of 
each time-lapse series (i.e., 36-h after cell seeding). We quantified 
the number of cells that were located beyond the first constriction 
and the total number of cells that entered the 5-µm-tall channels. All 
experimental results are based on at least three independent ex-
periments. Statistical analysis of transit times was determined using 
a Kruskal–Wallis test with Dunn’s multiple comparisons because the 
transit times did not follow a Gaussian distribution. Fisher’s exact 
test was used to compare the fraction of cells that had passed the 
first constriction between different conditions. The SE of the cell 
fraction was calculated according to the equation describing the SE 
for a binomial distribution:
p p
nSE
(1 )
=
−



where p is the fraction of cells that passed through the first row of 
constrictions and n is the total number of cells. Statistical tests were 
performed in GraphPad Prism.
Atomic force microscopy
Cells were seeded on polyacrylamide gels with 2.7-kPa stiffness for 
18 h. Hydrogels were then placed on the center of a standard mi-
croscopy slide and anchored using two-sided tape. Cells were kept 
hydrated in a droplet of HEPES-buffered medium (at room tem-
perature) while force measurements were performed on an Asylum 
Research (Santa Barbara, CA) MFP-3D atomic force microscope. 
Sigma-Aldrich; 700062, Invitrogen; V284, Santa Cruz Biotechnology), 
phospho–FAK-tyrosine 397 (44-625G, Invitrogen), vimentin (D21H3, 
Cell Signaling), β-catenin (8480, Cell Signaling), K14 (PRB-115P, Co-
vance), K8+18 (20R-CP004, Fitzgerald Industries), PINCH (EP1944, 
Abcam), ILK (611803, BD), and Alexa Fluor–phalloidin (Invitrogen) 
were used. Secondary antibodies used include Alexa Fluor goat 
anti-mouse, anti-rabbit, and anti-rat (488, 568, and 633 conjugates). 
For ILK immunofluorescence (IF), cells were fixed in 100% ice-cold 
methanol.
Microscopy and analysis
Unless otherwise noted, SAIM, TFM, confocal, and spheroid inva-
sion assay imaging were performed on motorized total internal re-
flection fluorescence (TIRF) inverted microscopes (Ti-E Perfect Focus 
System; Nikon) controlled by MetaMorph (Molecular Devices) and 
Nikon Elements software and equipped with 488-, 561-, and 640-
nm lasers, 350/50 epifluorescence, a CSU-X1 spinning-disk confocal 
unit (Yokogawa Electric Company), electronic shutters, motorized 
stage, a scientific complementary metal-oxide-semiconductor (sC-
MOS) camera (Zyla 5.5 megapixel, Andor; or Orca Flash, Hama-
matsu), and an electron-multiplying charge-coupled device 
(EMCCD) camera (QuantEM 512; Photometrics). Temperature and 
CO2 were controlled by an environmental chamber and propor-
tional integral derivative–controlled heater (In-Vivo Scientific). Sam-
ples were imaged with 100×/1.49 numerical aperture (NA) TIRF oil-
immersion, 40×/1.2 NA long-working-distance water-immersion, 
20×/0.75 NA air, and 10×/0.45 NA air objectives. For live-cell imag-
ing, phenol red–free growth medium with 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES; pH 7.4) was used. For 3D 
imaging, confocal image slices were taken at 0.2- or 1.0-µm slices 
and the individual planes were maximum intensity z-projected for 
2D visualization. Custom software packages for image analysis were 
written in Python, using ImageJ and the Eclipse Development Envi-
ronment in Linux. Images were subject to a Gaussian blur of 1.0 
pixel to smooth background noise. Intensity and colocalization mea-
surements of single confocal planes were calculated on a pixel-by-
pixel basis. Single-cell invasion, acini and cell protrusions, and cell 
adhesion length were quantified manually and verified qualitatively 
across three independent experiments. Acini cross-sectional area 
was quantified with the free-hand selection tool in ImageJ. Focal 
adhesion lifetimes were quantified manually and verified qualita-
tively across three independent experiments. SAIM was performed 
as described (Paszek et al., 2012; Rubashkin et al., 2014a), using 
data analysis and 3D visualization programs written in Matlab and 
Python using libraries distributed by Enthought.
Collagen invasion assays in 3D bioreactor
PyMT organoids were cultured in rBM (Corning) for 3–5 d. The or-
ganoids were isolated by solubilizing the gels using PBS-EDTA. The 
isolated organoids were subsequently embedded in 2.5 mg/ml col-
lagen I solution supplemented with fibronectin (1 µg/ml) and rBM 
(1%). The collagen gels were stretched in a tension bioreactor with 
0 or 10% strain for 72 h (Cassereau et al., 2015). Organoids were 
fixed with 1% PFA overnight for subsequent IF staining. Snail-YFP 
knock-in reporter tumor cells were kindly provided by Robert Wein-
berg (Ye et al., 2015). Tumor cells were cultured in rBM for 3–5 d and 
transferred to either untreated or ribose-stiffened collagen gels. Af-
ter 48 h, organoids were fixed and stained for indicated proteins.
Microchannel migration assays
Migration experiments in microfluidic devices were carried out as 
described previously (Davidson et al., 2014, 2015; Denais et al., 
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as well as kinetic rates for binding and unbinding of molecular 
clutches. Monte Carlo simulations were executed using a Gillespie 
stochastic simulation algorithm (Gillespie, 1977) run on in-house 
simulation computers using Matlab (MathWorks, Natick, MA), 
version 2014b. For a detailed description of the simulation and rele-
vant parameters, refer to the Supplemental Materials. The modified 
reinforcement model includes kinetic rates for addition of molecular 
clutches to the ensemble when a threshold force is reached by en-
gaged clutches:
K K n F F
n n
nadd add,base clutch threshold
clutch,max clutch
clutch,max
( )= × > × −
where Kadd is a basal first-order clutch addition rate constant, 
Fthreshold is a threshold force for clutch reinforcement signaling, and 
nclutch,max represents the total number of available clutches in the 
cell.
Cell areas in all simulations were approximated from simulation 
results by calculating the size of a disk-shaped cell from the length 
of an F-actin bundle. Actin filament assembly and cycling between 
G- and F-actin pools is calculated by an actin mass balance,
Actin G-actin F-actintotal [ ] [ ]  = +
where [G-actin] and [F-actin] are relative lengths of actin assigned to 
a soluble pool and filaments, respectively. Leading-edge protrusion 
velocity (vprotrusion) scales with the amount of available actin ([G-ac-
tin]) and is opposed by actin retrograde flow (vfilament) to give the 
following relationship for cell spreading rate:
V V Vspread protrusion filament= −
Traction force outputs from simulations are in one-dimensional 
(1D) forces, whereas experimental measures of traction force result 
in 2D stresses on a compliant gel. To draw comparisons between 
simulation and experiment, we used a previously described ap-
proach to derive a relationship between 1D forces and 2D stresses 
on a continuous substrate (Ghibaudo et al., 2008), as was previously 
described for stochastic simulations of cell traction (Elosegui-Artola 
et al., 2014, 2016). Here Ptraction is traction stress, and Ftraction is trac-
tion force:
P
F
r
P F
1 mtraction
traction
adhesion
2 2 traction tractionπ ( )= = µ → =
A compliant substrate is modeled as an elastic spring with stiff-
ness constant ksubstrate and effective Young’s modulus (Eeff) given by
E r E
9
4 ~1.3eff
substrate
adhesion
eff substrate
κ
π
κ=
×
→
Integrin force sensor measurements
The MTSs were adapted from sensors described previously 
(Morimatsu et al., 2015), using cysteine-maleimide chemistry to at-
tach the donor Alexa 546 dye and the acceptor Alexa 647 dye (Life 
Technologies). This modified MTS presents an RGD peptide derived 
from fibronectin TVYAVTGRGDSPASSAA. Perfusion chambers were 
attached to PEGylated coverslips as previously described (Morimatsu 
et al., 2015). Briefly, labeled MTSs (∼100 nM) were added to the flow 
cell and incubated for 30 min, followed by Pluronic F-127 (0.2% wt/
vol) for ∼1 min to prevent nonspecific cell attachment. All of these 
steps were preceded by a PBS wash to remove excess reagent from 
All samples were measured in liquid in contact mode using Nova-
scan 2.5-µm-radius beaded silica glass tip (k = 0.06 N/m) cantile-
vers, which were calibrated by the thermal tune method. Force 
measurements were collected at multiple points across the surface 
of the gels and cells at a maximum trigger force of 2.0 nN. The 
resulting force data were converted into elastic modulus using the 
Hertz Model program in IgorPro v6.22A. Measurements were also 
repeated with pointed-tipped Asylum Research TR400PB silicon 
nitride (k = 0.02 N/m) cantilevers, showing a similar trend. Surface 
plots were generated using the surf() function in Matlab. To deter-
mine cell elasticity, height cutoffs were chosen based on the height 
maps to assign pixel values associated with the cell versus the gel.
Micropipette aspiration
Micropipette aspiration through 3-µm-wide, 5-µm-high channels 
was performed using microfluidic devices fabricated as described in 
Denais et al. (2016). PDMS molds of the devices were filled with a 
2% bovine serum albumin (BSA)/0.2% FBS solution. Cells were tryp-
sinized and resuspended in the 2% BSA/0.2% FBS solution contain-
ing Hoechst 33342 for nuclear visualization. The cell suspension was 
perfused into the devices at constant pressure using a MCFS-EZ 
pressure controller (Fluigent). Channels were cleared by manual 
backflushing, and nuclear deformation of cells entering the chan-
nels was observed at 5 s intervals using a 20×/0.4 NA phase contrast 
objective and Hamamatsu ORCA Flash 4.0 V2 camera. Images were 
analyzed using a custom-written MATLAB algorithm.
Traction force microscopy
Cells were seeded overnight on PA gels with 100-nm fluorescent 
red beads. Images of cells and beads were taken at 20× before add-
ing 0.01% SDS to lyse the cells from the surface. A second picture of 
the beads was taken afterward that was later aligned via the ImageJ 
(http://rsb.info.nih.gov/ij) registration plug-in StackReg. To assess 
bead movement, a particle image velocimetry (PIV) program was 
implemented in ImageJ as described previously (Tseng et al., 2012). 
The iterative scheme included a first pass at 32/64 (i.e., interroga-
tion and search window size in pixels), followed by a second pass at 
16/32, all at a correlation threshold of 0.60. Cross-correlation PIV 
was used for traction measurements on gels of different stiffness, 
with three iterative schemes of 128, 64, and 32 as the interrogation 
window sizes. For PIV postprocessing, a normalized mean test 
(NMT) was performed as described (Tseng et al., 2012) with NMT 
noise of 0.2 and threshold of 2.0 as starting parameters. Parameters 
were altered to correct for erroneous vectors. The traction force was 
calculated by the Fourier transform traction cytometry (FTTC) 
method with a Poisson ratio of 0.5. For measurements of the PyMT/
Met1 and MCF10AT system, no regulation factor was used. To 
quantify the traction forces of MCF10A MECs on gels of different 
stiffness, we performed a regularization sweep to determine an op-
timal value and chose a constant of 10–10 for all of the conditions. 
Total and maximum traction forces were calculated using a mask of 
cell area from the bright-field image overlaid onto a per-pixel mag-
nitude plot of the traction vectors. The PIV and FTTC microscopy 
software for ImageJ was kindly made available by Qingzong Tseng 
(https://sites.google.com/site/qingzongtseng/tfm).
Motor-clutch model of cell traction
Stochastic simulations of a motor-clutch model of cellular traction 
were modified from previous models (Chan and Odde, 2008; Ban-
gasser et al., 2013). The base model contains eight parameters that 
describe numbers and physical properties of myosin motors and 
molecular clutches (e.g., integrin-mediated adhesion complexes), 
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cocktail (539134; Calbiochem). The lysates were incubated on ice 
for 1 h, followed by three sonication repeats using 10-s bursts at 
30% amplitude and 30-s rest (Sonics VCX130). Supernatant was col-
lected after 30-min centrifugation at 16,000 × g at 4 °C and incu-
bated with 500 µl of DPBS-prewashed streptavidin Dynabeads 
(65001; ThermoFisher) overnight at 4 °C on an end-over-end mixer.
Dynabeads were collected the next day and washed for 5 min at 
room temperature twice with 1 ml of buffer 1 (2% SDS in H2O), once 
with 1 ml of buffer 2 (0.1% sodium deoxycholate, 1% Triton X-100, 
500 mM NaCl, 1 mM EDTA, 50 mM HEPES, pH 7.5), once with 1 ml 
of buffer 3 (250 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate, 
1 mM EDTA, 10 mM Tris, pH 8.1), and three times with 1 ml of buffer 
4 (50 mM NaCl, 50 mM Tris, pH 7.4). After the last wash, beads were 
resuspended in 35 ml of SDS sample buffer saturated with biotin 
(250 mM Tris, pH 6.8, 0.57 M  β-mercaptoethanol, 8% SDS, 40% 
glycerol) and boiled at 95 °C for 10 min. Purified proteins were sepa-
rated on SDS–PAGE gel (NP0321BOX; ThermoFisher), stained with 
Coomassie dye (24615; ThermoFisher), and excised for mass spec-
trometry analysis.
Gel fractions were submitted to the Proteomics Facility at the 
Fred Hutchinson Cancer Research Center for mass spectrometry 
analysis. Briefly, desalted peptide samples were analyzed by liquid 
chromatography–electrospray ionization tandem mass spectrome-
try with a Thermo Scientific Easy-nLC II nano HPLC system coupled 
to a hybrid Orbitrap Elite ETD mass spectrometer using an instru-
ment configuration as described (Yi et al., 2003). In-line desalting 
was accomplished by using a reversed-phase trap column packed 
with Magic C18AQ (5-µm 200-Å resin; Michrom Bioresources, Au-
burn, CA), followed by peptide separations on a reversed-phase 
column packed with Magic resin and then directly mounted on the 
electrospray ion source.
Data analysis was performed using Proteome Discoverer 1.4 
(Thermo Scientific, San Jose, CA). The data were searched against 
a Uniprot human database that included common contaminants. 
Sequest HT was used for database searching, and Percolator was 
used for scoring. Data acquired from the Orbitrap Elite were pro-
cessed to generate normalized spectral count values for each pro-
tein. Similar to previously published techniques, each protein’s 
spectral counts were divided by the total number of spectral counts 
for that sample and then divided by the protein’s molecular weight 
(Horton et al., 2015). The resulting value was multiplied by 106 and 
log10-transformed to yield a score for each protein. Protein groups 
that had the same gene names (e.g., different isoforms or frag-
ments of a larger protein) were combined to decrease redundan-
cies in the analysis. Proteins or arrays were hierarchically clustered 
on the basis of an uncentered Pearson correlation using Cluster 3.0 
and visualized using Java TreeView, as described previously (Horton 
et al., 2015).
Human bioinformatics studies
To analyze survival as a function of transcriptomic data in human 
breast cancer patients, we used an online tool (www.kmplot.com; 
Györffy et al., 2013). The Affymetrix ID for paxillin was 201087_at. 
Briefly, the KMplot tool employs gene expression data and relapse-
free and overall survival information from the Gene Expression Om-
nibus, the European Genome-Phenome Archive, and The Cancer 
Genome Atlas (TCGA) from >4000 patients. To analyze the effect of 
specific genes in survival, patient samples were split into two groups 
by predefined metrics for calculating quantile expression. Affymetrix 
transcriptome data for a user-selected probe were analyzed in KM-
plot by autoselecting the best cutoff of gene expression, computing 
the median of expression over the entire database, and analyzing all 
the prior step. The cells were then added and incubated for at least 
1 h at 37 °C before imaging.
Images were taken using TIRF microscopy on an inverted micro-
scope (Nikon TiE) with an Apo TIRF 100× oil objective lens, NA 1.49 
(Nikon). Data were acquired with a 200-ms exposure using either an 
EMCCD camera (Andor iXon) or an sCMOS camera (Hamamatsu 
Orca Flash). The no-load FRET efficiency and gamma factor (γ) were 
measured at the single-molecule level as described previously. To 
calculate FRET index (FRETi), we divide the acceptor intensity, A 
(background subtracted), by the sum of the acceptor and donor (D) 
intensities (also background subtracted): FRETi = A/(A + D). Using 
the measured FRET index, we calculate the FRET efficiency (E), 
using the measured fraction of double-labeled sensor (α ≈ 0.90):
E
FRET
FRET FRET
i
i iα γ γ( )= − +
We then convert from FRET efficiency, E, to an average force per 
sensor molecule at each pixel, using a previously measured calibra-
tion curve modified to incorporate the photophysical properties of 
the dyes used here (Morimatsu et al., 2015).
A detailed explanation of calculations of the average force per 
sensor and total force per cell was given previously (Morimatsu 
et al., 2015). Briefly, to measure the average force per sensor, we 
first segmented the images from the paxillin-eGFP signal or the 
FRET index signal. These images were normalized, boxcar averaged 
with a rotating reference frame, and then thresholded to create a 
binary mask. The binary mask was used for a watershed algorithm to 
isolate individual islands, which were then combined and indexed 
with custom-written MATLAB code with minimum adhesion size of 
0.5 µm2. The average force per sensor was calculated by converting 
the FRET efficiency values to force values of individual pixels within 
the segmented regions. The total force per cell was calculated using 
FRET images of the entire cell taken on a Hamamatsu sCMOS cam-
era. The FRET values in the segmented pixels were then converted 
to force and summed over all of the adhesions in the entire cell.
3B superresolution analysis
The 3B algorithm uses a Bayesian analysis technique to determine 
the positions of fluorophores based on patterns of blinking and 
bleaching events (Cox et al., 2011). Data were recorded on an 
EMCCD camera (Andor iXon) for ∼200–300 frames at 20 frames/s. 
The images were then processed with the 3B algorithm on virtual 
machines hosted on Amazon’s EC2 cloud computing service (Hu 
et al., 2013). Each calculation ran on the compute-optimized c3.
large servers for ∼40 iterations. The positions and intensities of the 
fluorophores as determined by the 3B analysis were plotted on a 
coordinate system scaled by a factor of three, representing a three-
fold increase in effective resolution.
Proteomics experiment and analysis
The biotin ligase protocol was modified from the previously pub-
lished method (Roux et al., 2012), with some modifications outlined 
here. Four 10-cm dishes (∼20 million cells) of MCF10A MECs stably 
expressing BirA* constructs were cultured on tissue culture plastic 
and treated with TGFβ for 3 d. The cells were then incubated in 
medium supplemented with 50 µM biotin (B4639; Sigma-Aldrich) 
for 24 h before lysate collection. Cells were detached using trypsin-
EDTA, washed three times with cold DPBS, and resuspended in 
1.6 ml of ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 1 mM EDTA, 1 mM ethylene glycol tetraacetic acid, 0.5% so-
dium deoxycholate, 0.1% SDS, 1% NP-40) with protease inhibitor 
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patient subtypes as long as they were lymph-node positive in the 
2014 TCGA data set. All suggested quality controls were imple-
mented (Györffy et al., 2013).
Reverse-phase protein array (RPPA) data from TCGA patients 
were analyzed using an online tool (www.cbioportal.org; Gao et al., 
2013). Patients were separated into those with paxillin gene amplifi-
cation, mRNA up-regulation, or protein up-regulation; and those 
without significant changes in paxillin at the gene, mRNA, or protein 
level. These two patient groups were then compared for differences 
in activated and phosphorylated signaling proteins (including Src 
phosphorylation at tyrosine 416) via previously conducted RPPA 
arrays.
Statistics
Statistical analysis for two groups was performed with an unpaired, 
two-tailed Student’s t test or Wilcoxon rank sum test where appro-
priate. For multiple comparisons, an analysis of variance test and 
Holm–Bonferroni t test were performed. Calculations were imple-
mented in MATLAB, Python, and Prism.
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